Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Evidence for the aldo-keto reductase pathway of polycyclic aromatic trans-dihydrodiol activation in human lung A549 cells.

Park JH, Mangal D, Tacka KA, Quinn AM, Harvey RG, Blair IA, Penning TM.

Proc Natl Acad Sci U S A. 2008 May 13;105(19):6846-51. doi: 10.1073/pnas.0802776105. Epub 2008 May 12.

2.

Modification and uptake of a cisplatin carbonato complex by Jurkat cells.

Centerwall CR, Tacka KA, Kerwood DJ, Goodisman J, Toms BB, Dubowy RL, Dabrowiak JC.

Mol Pharmacol. 2006 Jul;70(1):348-55. Epub 2006 Apr 21.

PMID:
16632646
3.

Analysis of cytotoxicities of platinum compounds.

Goodisman J, Hagrman D, Tacka KA, Souid AK.

Cancer Chemother Pharmacol. 2006 Jan;57(2):257-67. Epub 2005 Jul 19.

PMID:
16028101
4.

Experimental and theoretical studies on the pharmacodynamics of cisplatin in jurkat cells.

Tacka KA, Szalda D, Souid AK, Goodisman J, Dabrowiak JC.

Chem Res Toxicol. 2004 Nov;17(11):1434-44.

PMID:
15540941
5.

Effects of cisplatin on mitochondrial function in Jurkat cells.

Tacka KA, Dabrowiak JC, Goodisman J, Penefsky HS, Souid AK.

Chem Res Toxicol. 2004 Aug;17(8):1102-11. Erratum in: Chem Res Toxicol. 2004 Sep;17(9):1297.

PMID:
15310242
6.

Immediate effects of anticancer drugs on mitochondrial oxygen consumption.

Souid AK, Tacka KA, Galvan KA, Penefsky HS.

Biochem Pharmacol. 2003 Sep 15;66(6):977-87.

PMID:
12963484
7.

Kinetic analysis of the reactions of 4-hydroperoxycyclophosphamide and acrolein with glutathione, mesna, and WR-1065.

Tacka KA, Dabrowiak JC, Goodisman J, Souid AK.

Drug Metab Dispos. 2002 Aug;30(8):875-82.

PMID:
12124304
8.

Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs.

Sadowitz PD, Hubbard BA, Dabrowiak JC, Goodisman J, Tacka KA, Aktas MK, Cunningham MJ, Dubowy RL, Souid AK.

Drug Metab Dispos. 2002 Feb;30(2):183-90.

PMID:
11792689

Supplemental Content

Loading ...
Support Center